Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...

Complications of Diabetes Mellitus

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

Diabetic Foot Ulcer

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Journal of medical genetics·2026

Same author

Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3.

Retina (Philadelphia, Pa.)·2026

Same author

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

NPJ genomic medicine·2025

Same author

Updates on surgical and nonsurgical innovations for macular hole treatment.

Survey of ophthalmology·2025

Same author

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Breast (Edinburgh, Scotland)·2025

Same author

Amniotic membrane placement without endotamponade for optic nerve coloboma with extensive serous retinal detachment in papillorenal syndrome: A case report.

American journal of ophthalmology case reports·2025

Same journal

Erratum.

Developments in ophthalmology·2021

Same journal

Pediatric Vitreoretinal Surgery and Integrated Intraoperative Optical Coherence Tomography.

Developments in ophthalmology·2021

Same journal

Integrated Intraoperative Optical Coherence Tomography for Pediatric Lamellar Corneal Transplant Surgery.

Developments in ophthalmology·2021

Same journal

The Use of Optical Coherence Tomography as an Intraoperative Adjunct of Oculoplastic Surgery.

Developments in ophthalmology·2021

Same journal

Integrated Intraoperative Optical Coherence Tomography in Strabismus Surgery.

Developments in ophthalmology·2021

Same journal

Use of Integrated Intraoperative Ocular Coherence Tomography in Pediatric Cataract Surgery: Thinking outside the Box.

Developments in ophthalmology·2021

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 24, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

Diabetic macular edema.

Fabio Patelli¹, Paolo Radice, Enrico Giacomotti

¹Vitreoretina Surgery, Department of Ophthalmology, Igea Clinic, Milan, Italy.

Developments in Ophthalmology

|September 9, 2014

Summary

This summary is machine-generated.

Diabetic macular edema (DME) can cause vision loss. Vitrectomy surgery may improve vision by reducing macular thinning and stabilizing vision, even without tractional forces.

More Related Videos

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Apr 24, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Area of Science:

Ophthalmology
Diabetology
Vascular Biology

Background:

Diabetic macular edema (DME) is a leading cause of vision loss in diabetes mellitus patients.
Current treatments like corticosteroids and anti-VEGF agents are not always effective.
The vitreous humor may contribute to DME through mechanical and physiological mechanisms increasing vascular permeability.

Purpose of the Study:

To explore the potential benefits of vitrectomy in managing diabetic macular edema.
To investigate the role of vitreous traction and its impact on macular edema.

Main Methods:

Review of existing literature on DME pathophysiology and treatment outcomes.
Analysis of the proposed mechanisms by which vitrectomy may alleviate DME.
Discussion of the potential advantages of early vitrectomy in both tractional and nontractional DME.

Main Results:

Vitrectomy can relieve mechanical traction on the macula, improving oxygenation and reducing DME.
Early vitrectomy, even in cases without significant traction, shows promise for rapid visual improvement and long-term stability.
Significant macular thinning has been observed following vitrectomy.

Conclusions:

Vitrectomy presents a potential therapeutic option for DME by addressing vitreous-related pathology.
Further research, including randomized controlled trials, is needed to compare vitrectomy with current standard treatments for DME.